A group of Anti-Abortion Organizations Sued U.S. Department of Health & Human Services (HHS) and the Food and Drug Administration (FDA) on Friday, in a bid to Reverse the FDA’s Approval of the Abortion Medication Mifepristone.
Lawyers from the Conservative Christian Legal group, Alliance Defending Freedom (ADF), filed the Suit in U.S. District Court for the Northern District of Texas in Amarillo, on behalf of the Alliance for Hippocratic Medicine, the American Association of Pro-Life Obstetricians and Gynecologists, the American College of Pediatricians, the Christian Medical & Dental Associations, and Four Doctors.
An HHS Spokesperson defended the Medication as Safe and Effective, and said that “denying women access to any essential care they need is downright dangerous and extreme.”
The Case, The ADF’s Lawyers argue that the FDA went beyond its Authority in Approving the Medication 22 years ago.
“The FDA’s approval of chemical abortion drugs has always stood on shaky legal and moral ground, and after years of evading responsibility, it’s time for the government to do what it’s legally required to do: protect the health and safety of vulnerable girls and women,” ADF Senior Counsel Erik Baptist said in a Statement.
After the Supreme Court turned Abortion Rights back to the States in June, Abortion Pills, often prescribed via Telemedicine, have become a way for People, seeking to End their Pregnancies in States with Abortion Bans or Restrictions to do so.
Last year, the FDA permitted Doctors to prescribe Mifepristone via Telemedicine and to send the Pills by Mail.
Abortion Rights Advocates want the FDA to assert that its Decisions to approve Drugs preempt State Abortion Bans and Restrictions.
In 2000, the FDA First Approved Mifeprex.
In 2016, the FDA Approved a Supplemental Application for Mifeprex based on Data and Information submitted by the Drug Manufacturer.
In 2019, the DA Approved a Generic version of Mifeprex, Mifepristone Tablets, 200 mg.
Mifeprex (mifepristone) is used, together with another Medication called Misoprostol, to End an Early Pregnancy, through 70 days Gestation, 70 days or less since the First day of a woman’s last Menstrual Period.
The Approved Mifepristone Dosing regimen is:
- On Day One: 200 mg of Mifeprex taken by mouth.
- 24 to 48 hours after taking Mifeprex: 800 mcg of Misoprostol is best taken with or after Meals and at Bedtime, unless otherwise directed by your Doctor. To help prevent loose stools, diarrhea, and abdominal cramping, always take this Medicine with Food or Milk.
NYC Wins When Everyone Can Vote! Michael H. Drucker
No comments:
Post a Comment